Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis
Crossref DOI link: https://doi.org/10.1158/1078-0432.CCR-18-2882
Published Online: 2019-03-01
Published Print: 2019-03-01
Update policy: https://doi.org/10.1158/crossmark_policy
Labadie, Brian W.
Bao, Riyue
Luke, Jason J.
Funding for this research was provided by:
Department of Defense (W81XWH-17-1-0265)
National Cancer Institute (P30CA014599-43S)
Institute for Translational Medicine/CTSA (NIH UL1 RR024999)